Bridge Formulation Private Limited

Bridge Formulation Private Limited - pharma in Varanasi, Uttar Pradesh, India. FY 2026 financials & compliance.
CIN U24100UP2010PTC041468 Incorporated 27 July 2010 ROC Uttar Pradesh HQ Varanasi, Uttar Pradesh, India
Active Private Limited Company pharma
Revenue · FY 2025
₹69.56 Lakh
▲ 121% YoY
Net profit · FY 2025
₹85,235
Net margin 1.2%
EBITDA · FY 2025
₹1.46 Lakh
EBITDA margin 2.1%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹10 Lakh
Secured borrowings
Company age
16 yrs
Est. 2010
Employees · EPFO
6
Provident fund records

About Bridge Formulation Private Limited

Data last updated:

Bridge Formulation Private Limited is a private limited company based in Varanasi, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 July 2010 and has been in existence for over 16 years.

The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24100UP2010PTC041468. Its GSTIN is 09AALCA7273M1ZZ (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹10 Lakh. It was formerly known as Abhyudaya Educational Private Limited. It is led by directors Nirmal Jyoti and Shailesh Chaubey.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S – 8/2A – 4H Unchava Lodge Gilat Bazar, Varanasi, Uttar Pradesh, India – 221002.

As per the financials filed for FY 2025, the company reported a revenue of ₹69.56 Lakh, a growth of 121% compared to the previous year. For the same year it recorded a net profit of ₹85,235 (net margin 1.2%) and EBITDA of ₹1.46 Lakh (EBITDA margin 2.1%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 10% over five years.

The company has about 6 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹10 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24100UP2010PTC041468
Registration Number 041468
Incorporation Date 27 July 2010
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

CIN history

Bridge Formulation has one previous CIN (Corporate Identification Number): U74900UP2010PTC041468. The current CIN is U24100UP2010PTC041468, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24100UP2010PTC041468Current
U74900UP2010PTC041468Previous

Contact details

Bridge Formulation Private Limited's registered office is in Varanasi, Uttar Pradesh. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    S – 8/2A – 4H Unchava Lodge Gilat Bazar, Varanasi, Uttar Pradesh, India – 221002
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Bridge Formulation Private Limited, buy the company report.

Comprehensive company report
Bridge Formulation Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Bridge Formulation is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Bridge Formulation Private Limited, buy the company report.

Financials of Bridge Formulation Private Limited

FY 2025 filings available

Bridge Formulation Private Limited reported revenue of ₹69.56 Lakh (up 121% YoY) for FY 2025.

Revenue · FY 2025
₹69.56 Lakh ▲ 121%
Net profit · FY 2025
₹85,235 margin 1.2%
EBITDA · FY 2025
₹1.46 Lakh margin 2.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 121%
3 years · compounded
▼ 10%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▲ 62%
3 years · compounded
▲ 3%
5 years · compounded
▲ 15%

Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 121% growth in the latest year. EBITDA rose 62% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.46 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹85,235
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin2.1%
Net Profit Margin1.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Bridge Formulation Private Limited, buy the company report.

Board of directors of Bridge Formulation Private Limited

Bridge Formulation has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Nirmal JyotiDirector10 May 201313 Years 6 MonthsCurrent
Shailesh ChaubeyDirector03 Jun 20251 Years 5 MonthsCurrent

Auditor

Bridge Formulation Private Limited is audited by BISEN & ASSOCIATES for the financial year 2020.

Auditor firmFinancial yearFirm registration number
BISEN & ASSOCIATESFY 2020017192N

Shareholding

The shareholding of Bridge Formulation Private Limited is on record for 5 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2020FY 2019FY 2017FY 2016FY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Bridge Formulation Private Limited, buy the company report.

Charges & borrowings

Open charges
₹10 Lakh
Satisfied charges
None
Breakdown by lending institutions
State Bank of India₹0.10 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
04 Feb 2026101238004State Bank of India₹10 LakhOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Bridge Formulation Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Bridge Formulation Private Limited has a workforce of 6 employees on its EPFO records as of Nov 2025, across 1 active EPFO establishment.

Employee count
6
Active EPFO establishments
1

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2025-266
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22

To see the full employee and EPFO history of Bridge Formulation Private Limited, buy the company report.

GST

Bridge Formulation has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
09AALCA7273M1ZZUttar PradeshActive09 Nov 2017

To see the full GST registrations and return filing status of Bridge Formulation Private Limited, buy the company report.

Recent activity

Bridge Formulation Private Limited has 7 board changes on record since 2013: 3 appointments and 4 cessations. The latest: Pankaj Kumar Srivastava ceased to be Director on 07 Jun 2025.

Charges
A charge with State Bank Of India amounted to Rs. 10.00 Lakh with Charge ID 101238004 was registered on 04 Feb 2026.
AGM
Bridge Formulation Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Pankaj Kumar Srivastava ceased to be Director.
Appointed
Shailesh Chaubey was appointed as Director.
Filing
Bridge Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh I.
Ceased
Shikha Singh ceased to be Director.
Ceased
Umesh Singh ceased to be Director.
Appointed
Pankaj Kumar Srivastava was appointed as Director.
Ceased
Mukesh Singh ceased to be Director.
Appointed
Nirmal Jyoti was appointed as Director.
Incorporation
27 Jul 2010
Bridge Formulation Private Limited was registered on 27 Jul 2010 with Roc Uttar Pradesh I & aged 16 years 3 months as per MCA records.

Frequently asked questions

Bridge Formulation is an active private limited company based in Varanasi, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 July 2010 (16+ years old) and is registered under CIN U24100UP2010PTC041468.

Bridge Formulation has 2 current directors:

The latest financial statements of Bridge Formulation on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Bridge Formulation is 09AALCA7273M1ZZ, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Bridge Formulation is U24100UP2010PTC041468. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Bridge Formulation was incorporated on 27 July 2010, making it 16+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.

Pankaj Kumar Srivastava ceased to be Director on 07 Jun 2025. Shailesh Chaubey was appointed as Director on 03 Jun 2025. Shikha Singh ceased to be Director on 01 Jul 2024. Bridge Formulation has 7 board changes on record in total.

The registered office of Bridge Formulation is at S – 82A – 4H Unchava Lodge Gilat Bazar, Varanasi, Uttar Pradesh, India – 221002.

Bridge Formulation operates in the pharma industry, in the drug formulation and development segment.

Bridge Formulation has open charges of ₹10 Lakh and no satisfied charges on record as per latest MCA filings.